The available database comprises research projects in Fisheries, Aquaculture, Seafood Processing and Marine Biotechnology active in the time period 2003-2022.
BlueBio is an ERA-NET COFUND created to directly identify new and improve existing ways of bringing bio-based products and services to the market and find new ways of creating value from in the blue bioeconomy.

More information on the BlueBio project and participating funding organizations is available on the BlueBio website: www.bluebioeconomy.eu

Last Update: 2024/06/19

NA
Marine Biotechnology
Aquaculture
Host immunity and skin microbiome interplay: Importance for protection against sea lice infestation in Atlantic salmon
National Programme
National
Øystein Evensen
oystein.evensen@nmbu.no
NMBU - Norwegian University of Life Sciences (Norway)
NA - Cermaq Norway AS (Norway)NA - Grieg Seafood Finnmark AS (Norway)IMR - Institute of Marine Research (Norway)NA - Lerøy Norway Seafoods AS (Norway)NVI - Norwegian Veterinary Institute (Norway)UCSD - University of California (United States of America)
2019
2022
€ 571,950
https://www.fhf.no/prosjekter/prosjektbasen/901566/
Previous attempts to develop vaccines against salmon lice infection in salmon have not produced satisfactory results. Candidate antigens are difficult to identify and test for their ability to induce efficacious immune responses. Several studies have used a concealed antigen strategy (transferred from the Boophilus microplus vaccine in cattle) and while results initially were promising, results have been difficult to reproduce. NMBU/Aqua has participated in the Sea Lice Research Center (SLRC) with a focus on immunomodulation of the host, including to develop immunoprophylactic principles against infection. We have worked with vaccination modalities using DNAprime/ protein boost but again, results have not been promising. For this reason we have taken a different path with an idea that lack of protection can be related to amount of antigen used for immunization/ low corresponding antibody responses. Lice antigens have been prepared from sea lice and used for immunization of salmon at high antigen load. With this approach we have obtained a 65% reduction in sea lice numbers (compared to controls) and a heavy infection load. Main objective: To establish a protocol for vaccination combined with skin microbiome engineering that increase the resistance towards lice infection in Atlantic salmon. Sub-objectives: • To identify protective antigens of lice preparations for subsequent use of recombinant antigen design and vaccine delivery using a ""reverse vaccinology"" approach. • To characterize, quantify and detail the impact of sea lice infection on the skin microbiome in Atlantic salmon in terms of its taxon presence/absence and relative abundance. • To test these prophylactic interventions at laboratory scale and in small scale field studies.
Parasite; Genetic; Fish; Microbiome; Vaccines development; Salmon;
Not associated to marine areas
map png
If there is any incorrect or missing information on this project please access here or contact bluebio.database@irbim.cnr.it
/* */